Will Express Scripts Destroy the Cure for Cancer?
In today's business environment, socialist and fascist elements are sometimes mixed in with legitimate, private companies. One such government entity that is traded on the NASDAQ is Express Scripts (ESRX).Express Scripts can be described as a government manager. It uses the outcome of socialist bargaining to extort money in the area of medicine. Its primary source of growth is found in its ability to inflict a reign of terror against bio-tech and Big Pharma companies. Since Express Scripts produces nothing, its only tool to this end is the bureaucratic connections and strangleholds it can tap into to punish the legitimate, private businesses in the medical market.
The mainstream media is setting up Express Scripts' (ESRX) next big move--cancer drugs. Just as it did with the consideration of multiple hepatitis C medicines--where government regulators did not exclude several treatments long enough for their buddies at Express Scripts to talk down their prices, its success with that strategy has wet its appetite for more.
Some may argue that Express Scripts is engaging in legitimate price negotiation. But, considering what goes on behind the scenes--where government regulators make it clear that if Big Pharma does not cooperate in price reduction, it will not be able to sell its products at all, there is nothing legitimate about Express Scripts' behavior.
Finally, to make a practical point concerning the danger of cancer, the immutable laws of economics are at work here. If Big Pharma finds that it is making insignificant profits in the fight against cancer, even if one does not have to worry about that disease right now, what about 10 years from now? By not opposing what Express Scripts (ESRX) and their government buddies are doing, in essence one is killing oneself in the future.
Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)